-

63rd ASH Annual Meeting & Exposition

American Society of Hematology (ASH) 63rd annual meeting with both in-person and virtual participation at the Georgia World Congress Center in Atlanta, Georgia. ASH Annual Meeting & Exposition is the largest event in malignant and non-malignant hematology.

The agenda for Oncopeptides posters.

Saturday, December 11, 2021, 5:30-07:30 PM EST

  • Session name: 605. Molecular Pharmacology and Drug Resistance: Lymphoid Neoplasms: Poster I
  • Single Cell RNA Sequencing Identifies Potential Molecular Indicators of Response to Melflufen in Multiple Myeloma
    • Lead Author: Philipp Sergeev
    • Publication Number: 1194

Sunday, December 12, 2021, 6:00-8:00 PM EST

  • Session name: 653. Myeloma and Plasma Cell Dyscrasias: Clinical-Prospective Therapeutic Trials: Poster II
  • Melflufen/Dexamethasone Compared With Pomalidomide/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma – Age Subgroup Analysis of Older Patients
    • Lead Author: Marivi Mateos
    • Publication Number: 2741
  • Melflufen/Dexamethasone Compared With Pomalidomide/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma – Safety and Tolerability Analysis
    • Lead Author: Paul M Richardson
    • Publication Number: 2732

Upcoming events

Annual General Meeting 2022

The Annual General Meeting in Oncopeptides AB (publ) will be held on Tuesday June 28, 2022, (changed from May 19, 2022) in Stockholm, Sweden. Due to the extraordinary situation resulting from the covid-19 pandemic, Oncopeptides’ Annual General Meeting will be carried out through advance voting (postal voting) pursuant to temporary legislation. No meeting with the possibility to attend in person or to be represented by a proxy will take place. Hence, the Annual General Meeting will be held without physical presence.

Silent Period

-

Silent Period

-

Silent Period

-

Year-end report 2022

08:00 CET